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The effects of la,25-dihydroxyvitamin D, (la,25-(OH),D,) on Ca a + levels and phospholipid metabolism were studied in isolated nuclei prepared 
from rat liver. Nuclear Ca*+ concentration was estimated with the fluorescent indicator Fura 2. In agreement with previous reports, ATP (1 mM) 
a’ produced a rapid increase in nuclear Ca from 188 + 25 to 593 &- 121 nM. Exposure to la,25-(OH&Da (20 nM) also produced a rapid increase 
in nuclear Ca2’ to 402+71 nM. The lp epimer of la,25-(OH)zD3 had no effect. Nuclear phosphatidylinositol was labeled by incubation with 
[yJ2P]ATP for 3 h. lcr,25r(OH)zD, produced a two-fold increase in P2P]lysophosphatidylinositol (LPI) within 5 min from 44 f 11 to 87 f 19 cpm/2.5 
x 10’ nuclei. lB,25-(OH)zDs had no effect on P*P]LPI production. Exposure of nuclei to exogenous LPI (15 GM) produced an instantaneous in- 
crease in nuclear Ca2+ to 372+81 nM, comparable to ATP and la,25-(OH)zD,. The rapid effects of la,25-(OHXD, on phospholipid metabolism - 
and Ca* + in isolated nuclei suggest hat the steroid may exert effects distinct from the well-characterized receptor-mediated changes in gene expres- 
sion. 
la,25-(OHXD,; Caz+, nuclear; Phosphatidylinositol, nuclear 
1. INTRODUCTION 
Ca2+ plays an important role in the regulation of nu- 
clear function. Intracellular Ca2+ may serve as a signal 
to regulate gene expression and the growth of trans- 
formed cells [ 1,2]. Increases in intracellular Ca2+ have 
been shown to rapidly alter the expression of the fios 
and jun proto-oncogenes [3,4] and increments in cell 
and nuclear Ca2+ precede DNA fragmentation [5-71. 
The ion also stimulates poly(ADP-ribosylation) of nu- 
clear proteins [6]. Poly(ADP-ribosylated) histones ap- 
pear to be intermediates in nuclear processes involving 
DNA strand breaks [8]. 
The steroid hormone, lLu,25dihydroxyvitamin D3 
(la,25(OH)zD3), has traditionally been thought to 
simply play a role in the regulation of plasma Ca’+. 
However, in addition to its effects on extracellular 
Ca’+, the seco-steroid rapidly and specifically increases 
intracellular Ca2+ in hepatocytes [9-121 and a variety of 
other cell types [13-161. The hormone has also been 
shown to regulate a variety of gene products [17-221. 
The physiologic consequences of these nuclear effects 
of the hormone include alterations in cell proliferation 
and differentiation [17]. Since both intracellular Ca2+ 
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and 1~,25-(OH)zDs appear to be involved in nuclear 
function and since Ca2+ has been reported to modulate 
the effect of lcu,25-(OH)zD3 on calbindin gene expres- 
sion [23,24], we tested the hypothesis that the seco- 
steroid alters nuclear Ca’+ content. The results 
demonstrate that the hormone rapidly increased Ca2+ 
within the nucleus and altered nuclear phospholipid 
metabolism. These rapid nuclear actions of 
la,25-(OH)2D3 may serve to modulate the genomic ef- 
fects of the hormone. 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats, 250-300 g, were sacrificed under ket- 
amine anesthesia. The livers were removed, homogenized, and frac- 
tionated by differential centrifugation by the method of Nicotera [7] 
to isolate the nuclei. The purified nuclei, confirmed by phase contrast 
microscopy, were resuspended in medium containing: 125 mM KCl, 
2 mM KaHP04,25 mM Hepes, 4 mM MgClr, and 2 mM EGTA, pH 
7.0. Ca’+ was added to an estimated free concentration of 200 nM to 
approximate cytosolic Ca2+ concentrations. Nuclei, 1 x lO’/ml, were 
loaded with 1 pM Fura 2/AM (Molecular Probes, Eugene, OR) for 
1 h at 4°C. Nuclei were washed, resuspended, and equilibrated at 
37°C under an atmosphere of 95% Oa:5% CO2 for 15 min. 
Nuclear CaZf was estimated from the fluorescence of Fura 2 [7] 
determined with a Perkin-Elmer 650-10s canning fluorescence spec- 
trophotometer (Perkin-Elmer, Norwalk, CT). Fluorescence intensity 
was monitored at an emission wavelength of 510 nm and with the ex- 
citation wavelength alternating between 340 and 380 nm. Nuclear 
Ca*+ content was calculated by the equation: 
Ca’+ = Kd(R - Rmi.)/(Rm,x - R) [&z/&z] 
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where fluorescence (R) is the ratio of fluorescence at 340/380, max- 
imal fluorescence (Rmax) is the ratio at 340/380 of nuclei lysed by the 
addition of Triton X-100, and minimal fluorescence (R& is the ratio 
at 340/380 of nuclei incubated in the presence of EGTA to chelate 
Ca*+. The Kd was calculated to be 182 nM and the Sn/Sm constant 
2.82 in our system [lo]. la,25-(OH)zDs (courtesy of Dr M. Uskovic, 
Hoffmann-La Roche, Inc., Nutley, NJ), 1/3,25dihydroxyvitamin D3 
(lfl,25-(OH)zD3), lysophosphatidylinositol (LPI) (Avanti, Birm- 
ingham, AL), and ATP (Boehringer Mannheim, Indianapolis, IN) 
were added in a volume of 0.01 ml to 1 ml of nuclei at 37°C. 
Phospholipids in rat liver nuclei were labeled by incubation with 
[y-‘*P]ATP (spec. act. 2 mCi/ml, DuPont, Boston, MA) at a concen- 
tration of 0.01 mCi/lO’ nuclei for 3 h before exposure to alcohol, 
la,25-(OH)pDs (20 nM), or l&,25-(OH)zDs (20 nM) for 5 min. Nu- 
clei were centrifuged at 250 x g for 1 min and the nuclear pellet 
dissolved in 3 ml of CHsCI:CHsOH:HCI (100:50: 1). 0.2 M KC1 
solution (1 ml) was added to each sample, and phases separated by 
centrifugation at 250 x g for 1 min. The aqueous phase was removed 
and the lower lipid phase was re-extracted with 1 ml of 0.2 M 
KC1 : CH3OH (1: 1). The lipid fraction was dried, dissolved in 50 ~1 
CHCls, and applied to preactivated (110°C for 30 min) 10 x 10 cm 
silica gel 60 HPTLC plates (Merck, Darmstadt, FRG). The phospho- 
lipids were separated by development in the first dimension with 
CHCls:CHsOH:NH40H (60:30:7) and at right angles with 
CHs(CH&OH: CHsCOzH : Hz0 (6: 1: 1) in the second phase. Phos- 
phatidylinositol (PI) (Sigma, St. Louis, MO) and LPI standards were 
cochromatographed for correct identification of individual phospho- 
lipids [12]. Phospholipids were detected on individual plates by ex- 
posure to 6-p-toluidino-2-naphthalene sulfonic acid (TNS) (Eastman 
Kodak, Rochester, NY) [25] and by autoradiography on Kodak 
Diagnostic film X-OMAT-AR. A fine mist of the TNS solution 
(1 mM TNS in 50 mM Tris-HCI, pH 7.4) was sprayed on the plates, 
identifying the phospholipids as bright spots on a dark background. 
Radioactivity in the individual phospholipids was quantified by scrap- 
ing the identified spot and counting in 3 ml Econofluor (New England 
Nuclear/DuPont, Boston, MA) in a Beckman LS 1701 Liquid Scin- 
tillation Counter. 
3. RESULTS AND DISCUSSION 
In agreement with previous reports [7], ATP (1 mM) 
rapidly increased the Ca2+ concentration in isolated nu- 
clei as measured by an increase in the fluorescence of 
the Ca2+-sensitive probe Fura 2 (fig.1). lc~,25-(OH)zD3 
produced a similar effect in isolated nuclei, although 
lesser in magnitude (fig.1). lB,25-(OH)zD3, an epimer 
of la,25(OH)2D3 which does not affect Ca2+ metabo- 
lism, did not alter nuclear fluorescence (fig.1). LPI, a 
lysolipid which mimics the la,25(OH)zD3 effects on 
cytosolic Ca2+ in isolated hepatocytes [ 121, also increas- 
ed nuclear Ca2+ (table 1). After 5 min of exposure to 
agonists, the nuclear free Ca2+ concentration was in- 
creased by ATP, la,25-(OH)zDs, and LPI, while 
l,B,25-(OH)zD3 remained ineffective (table 1). 
Cytosolic Ca2+ is regulated in part by changes in PI 
metabolism. To determine whether phospholipid me- 
tabolism in the nucleus was altered by agonists, we ex- 
amined PI metabolism in the isolated liver nuclei. Nu- 
clear PI was labeled with 32P by incubation with 
[Y-~~P]ATP. Exposure of nuclei to lcu,25-(OH)zD3 pro- 
duced a rapid increase in [32P]LPI, suggesting the 
steroid may alter phospholipase A2 in this nuclear sys- 
tem (table 2). Concomitant with the increase in nuclear 
free Ca2+, lcu,25-(OH)zD3 enhanced the production of 
[32P]LPI in the nuclear membrane by 98%, while 
l&,25-(OH)2D3 was without effect (table 2). 
Previous studies from our laboratory have 
demonstrated that lcu,25-(OH)zDr rapidly increases 
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Fig. 1. Fura 2 fluorescence in isolated nuclei. To continuously monitor nuclear Ca’+, the changes in Fura 2 fluorescence were determined at 340 nm 
excitation and the Ca2+ content estimated from changes in fluorescence. Representative tracings are shown. For convenience, the fluorescent inten- 
sity is expressed as apparent Ca*+ content. The rapid alterations in fluorescence shown here at excitation 340 nm correspond to calculated Ca2+ 
concentrations. 
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Table 1 Table 2 
Increase in the apparent free Ca’+ concentration of isolated rat liver 
nuclei after exposure to ATP, lcu,25-(OH)zDp, lp,25-(OH)2D3, or 
Increase in [“P]lysophosphatidylinositol (LPI) in isolated rat liver 
nuclei after exposure to lcu,25-(OH)zD3 
LPI 
Ca2+ Increase 
(nM) (Ye) 
Control (n = 9) 188 + 25 - 
ATP (1 mM), (n = 7) 593 * 121 215* 
la,25-(OH)zDg (20 nM), (n = 9) 4022 71 114** 
1@,25-(OHhD3 (20 nM), (n = 5) 210* 68 12 
LPI (15 PM), (n = 7) 372+ 81 98** 
The free Ca2+ concentration was measured by Fura 2 fluorescence 
after 5 min exposure to agonists. Values represent he mean * SD. 
Numbers in parentheses (n) indicate the number of observations. Pro- 
bability of difference was determined by Duncan’s test for multiple 
[32P]LPI Increase 
(cpm/2.5 x 10’ nuclei) (%) 
Control (n = 6) 44f 11 
la,25-(OH)zDn (20 nM), (n = 5) 87 f 19* 98’ 
lp,25-(OH)2D3 (20 nM), (n = 4) 47f 19 7 
Values represent the mean f SD. Numbers in parentheses (n) indicate 
the number of observations in each group. Probability of difference 
was determined by Duncan’s test for multiple comparisons 
*Significantly greater than other groups (P< 0.05) 
comparisons 
* Significantly greater than all other groups (P< 0.05) 
**Significantly greater than control and lfl,25-(OH)2Ds (P<O.OS) 
hepatocyte cytosolic Ca’+, and this action appears to be 
linked to changes in phospholipid metabolism, 
specifically the generation of LPI [g-12]. In the present 
studies, 1~,25-(OH)ZDJ was shown to exert rapid, 
stereospecific effects on Ca2+ and phospholipid 
metabolism in a cell-free system, isolated nuclei. Since 
la,25(OH)2D3 produced an increase in LPI (table 2) 
over the same time period as an increase in nuclear Ca2+ 
(table l), and exposure of isolated nuclei to LPI also in- 
creased Ca2+ (table l), the data suggest that this 
lysolipid may serve as a signal for these rapid nuclear 
actions of lcz,25-(OH)zD3. 
The actions of lcu,25-(OH)zD3 were stereospecific in 
that the epimer l/3,25-(OH)zDs failed to produce an in- 
crease in nuclear Ca2+ (table 1) or LPI (table 2). 
Similarly, the l,B epimer does not alter cytosolic Ca2+ or 
LPI in intact hepatocytes [12]. This epimer is unable to 
increase plasma Ca2+ or enhance intestinal Ca2+ trans- 
port [26]. The lack of effect of l,f3,25-(OH)2D3 on in- 
testinal Ca2+ transport has been attributed to its inabili- 
ty to bind to, or to displace 1~,25-(OH)2D3 from, the 
cytosolic receptor thought to mediate this action [26]. 
Exogenous nucleotide is necessary to generate new 
phospholipid synthesis which we can detect by auto- 
radiography (table 2). It appears that la,25-(OH)2D3 
can induce the deacylation of pre-existing nuclear phos- 
pholipids, perhaps by activating phospholipase A pres- 
ent in the nuclear matrix [27], to generate the LPI signal 
and subsequent Ca2+ increments. ltu,25-(OH)zD3 has 
previously been shown to increase phospholipase A ac- 
tivity in intact hepatocytes [ 11,121. Like Ca2+, the phos- 
pholipid environment has been postulated to be impor- 
tant in the regulation of nuclear functon. The inositol 
phospholipids in particular have been shown to 
modulate T(IS gene activity during mitogenic stimulation 
[28-301 and to stimulate the initiation of DNA synthesis 
[31]. Recent studies indicate that phospholipid phos- 
phorylation takes place in isolated rat liver nuclei [32]. 
The data suggested that the nucleus, and especially the 
nuclear periphery, is a cell compartment in which poly- 
phosphoinositide synthesis occurs; this might be related 
to the progression of PI metabolism-dependent signals 
to the genetic apparatus [32]. We have not only con- 
firmed that phospholipid metabolism takes place in the 
nucleus, but have demonstrated that it can be hor- 
monally modulated (table 2). 
Although ATP, lcu,25-(OH)2D3, and LPI all increas- 
ed nuclear Ca2+, the effects of the hormone and LPI 
were apparent in the absence of ATP. Therefore, exo- 
genous nucleotide is not necessary for la,25-(OH)2D3- 
and LPI-induced increments in nuclear Ca2+. Previous 
studies have suggested that nuclear Ca2+ accumulation 
is the result of active transport of Ca2+, based upon 
ATP dependency and modulation by inhibitors of 
calmodulin [7]. Neither la,25-(OH)zDs nor LPI would 
directly provide a suitable energy source for such active 
transport. If increased nuclear Ca2+ truly reflects ac- 
cumulation against an electrochemical gradient, the ef- 
fects of lcu,25-(OH)2D3 and LPI may be the result of 
lysolipid-induced alterations in the nuclear membrane 
properties to other ions, such that the Ca2+ gradient is 
altered and nuclear Ca2+ content is increased. 
In conclusion, this study demonstrates rapid, stereo- 
specific effects of l&,25-(OH)zD3 on the free Ca2+ of 
isolated rat liver nuclei. The hormone also rapidly and 
stereospecifically alters the deacylation of PI to LPI, 
which in turn can increase nuclear free Ca2+. These 
la,25-(OH)2D3 effects on nuclear Ca2+ and phospho- 
lipids may modulate the hormone’s actions on cell 
growth and oncogene expression. 
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